.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A systematic review and meta-analysis assessed the outcomes and complications of intra-arterial chemotherapy for retinoblastoma across 20 published studies involving 873 patients and 1,467 eyes. The evidence suggested that IAC can achieve substantial globe salvage, including in advanced disease, but only one included study was comparative and many studies were retrospective. Retinal detachment and transient systemic symptoms were among the reported complications, while long-term evidence on metastasis remained limited. The review therefore supports IAC as an important part of contemporary retinoblastoma care while emphasising that evidence quality is not equivalent to the strength of the published success rates. For HCPs, the clinical implication is that IAC should be used within specialised multidisciplinary ocular-oncology programmes with clear patient selection and long-term surveillance. The paper is directly relevant to AIOC's focus on retinoblastoma and globe-salvage strategies.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A systematic review and meta-analysis assessed the outcomes and complications of intra-arterial chemotherapy for retinoblastoma across 20 published studies involving 873 patients and 1,467 eyes. The evidence suggested that IAC can achieve substantial globe salvage, including in advanced disease, but only one included study was comparative and many studies were retrospective. Retinal detachment and transient systemic symptoms were among the reported complications, while long-term evidence on metastasis remained limited. The review therefore supports IAC as an important part of contemporary retinoblastoma care while emphasising that evidence quality is not equivalent to the strength of the published success rates. For HCPs, the clinical implication is that IAC should be used within specialised multidisciplinary ocular-oncology programmes with clear patient selection and long-term surveillance. The paper is directly relevant to AIOC's focus on retinoblastoma and globe-salvage strategies.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
